Cargando…
The Application of Liver Stiffness Measurement in Residents Without Overt Liver Diseases Through a Community-Based Screening Program
The application of liver stiffness measurement (LSM) by transient elastography (TE) in general population remains to clarify. This cohort study aimed to examine the usefulness of TE and to identify factors associated with significant liver fibrosis in community-based population. We conducted a hepat...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998410/ https://www.ncbi.nlm.nih.gov/pubmed/27015215 http://dx.doi.org/10.1097/MD.0000000000003193 |
_version_ | 1782449936387801088 |
---|---|
author | Cheng, Pin-Nan Chiu, Yen-Cheng Chiu, Hung-Chih Chien, Shih-Chieh |
author_facet | Cheng, Pin-Nan Chiu, Yen-Cheng Chiu, Hung-Chih Chien, Shih-Chieh |
author_sort | Cheng, Pin-Nan |
collection | PubMed |
description | The application of liver stiffness measurement (LSM) by transient elastography (TE) in general population remains to clarify. This cohort study aimed to examine the usefulness of TE and to identify factors associated with significant liver fibrosis in community-based population. We conducted a hepatitis screening program in 2 remote villages of Southern Taiwan. All residents participated voluntarily and received questionnaire evaluation, blood tests, abdominal sonography, and LSM by TE. Residents with any one of following criteria including hepatitis B virus infection, hepatitis C virus infection, more than moderate alcohol drinking, and failure to obtain valid or reliable LSM were excluded. There were 831 residents participated in program. The valid and reliable LSM were obtained in 98.3% and 96.3% of residents, respectively. Finally, a total of 559 residents including 283 residents with nonalcoholic steatotic fatty liver disease (NAFLD) were enrolled for analysis. The mean liver stiffness was 4.9 ± 1.9 kPa. The liver stiffness increased in residents with diabetes mellitus (DM), higher body mass index (BMI), hypertension, abnormal waist–hip circumference ration (WHR), higher waist circumference (WC), and presence of fatty liver. Higher body weight, higher BMI, higher WC, abnormal WHR, abnormal aspartate aminotransferase (AST), abnormal alanine aminotransferase (ALT), and DM were the factors associated with significant fibrosis (liver stiffness ≥7 kPa) in either all participants or NAFLD residents. As determined by multivariate analysis, abnormal AST values and DM were the 2 independent factors in all participants (abnormal AST: OR 3.648, 95% CI 1.134–11.740, P = 0.03; DM: OR 2.882, 95% CI 1.282–6.478, P = 0.01) and in residents with NAFLD (abnormal AST: OR 4.197, 95% CI 1.154–15.262, P = 0.03; DM: OR 3.254, 95% CI 1.258–8.413, P = 0.02). LSM by TE is a useful screening tool in community. In residents, who were absence of chronic hepatitis virus infection or consumed less than moderate alcohol drinking, exhibited DM or abnormal AST values may consider a substantial group with significant fibrosis in community. |
format | Online Article Text |
id | pubmed-4998410 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-49984102016-09-02 The Application of Liver Stiffness Measurement in Residents Without Overt Liver Diseases Through a Community-Based Screening Program Cheng, Pin-Nan Chiu, Yen-Cheng Chiu, Hung-Chih Chien, Shih-Chieh Medicine (Baltimore) 4500 The application of liver stiffness measurement (LSM) by transient elastography (TE) in general population remains to clarify. This cohort study aimed to examine the usefulness of TE and to identify factors associated with significant liver fibrosis in community-based population. We conducted a hepatitis screening program in 2 remote villages of Southern Taiwan. All residents participated voluntarily and received questionnaire evaluation, blood tests, abdominal sonography, and LSM by TE. Residents with any one of following criteria including hepatitis B virus infection, hepatitis C virus infection, more than moderate alcohol drinking, and failure to obtain valid or reliable LSM were excluded. There were 831 residents participated in program. The valid and reliable LSM were obtained in 98.3% and 96.3% of residents, respectively. Finally, a total of 559 residents including 283 residents with nonalcoholic steatotic fatty liver disease (NAFLD) were enrolled for analysis. The mean liver stiffness was 4.9 ± 1.9 kPa. The liver stiffness increased in residents with diabetes mellitus (DM), higher body mass index (BMI), hypertension, abnormal waist–hip circumference ration (WHR), higher waist circumference (WC), and presence of fatty liver. Higher body weight, higher BMI, higher WC, abnormal WHR, abnormal aspartate aminotransferase (AST), abnormal alanine aminotransferase (ALT), and DM were the factors associated with significant fibrosis (liver stiffness ≥7 kPa) in either all participants or NAFLD residents. As determined by multivariate analysis, abnormal AST values and DM were the 2 independent factors in all participants (abnormal AST: OR 3.648, 95% CI 1.134–11.740, P = 0.03; DM: OR 2.882, 95% CI 1.282–6.478, P = 0.01) and in residents with NAFLD (abnormal AST: OR 4.197, 95% CI 1.154–15.262, P = 0.03; DM: OR 3.254, 95% CI 1.258–8.413, P = 0.02). LSM by TE is a useful screening tool in community. In residents, who were absence of chronic hepatitis virus infection or consumed less than moderate alcohol drinking, exhibited DM or abnormal AST values may consider a substantial group with significant fibrosis in community. Wolters Kluwer Health 2016-03-25 /pmc/articles/PMC4998410/ /pubmed/27015215 http://dx.doi.org/10.1097/MD.0000000000003193 Text en Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by-nd/4.0 This is an open access article distributed under the Creative Commons Attribution-NoDerivatives License 4.0, which allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author. http://creativecommons.org/licenses/by-nd/4.0 |
spellingShingle | 4500 Cheng, Pin-Nan Chiu, Yen-Cheng Chiu, Hung-Chih Chien, Shih-Chieh The Application of Liver Stiffness Measurement in Residents Without Overt Liver Diseases Through a Community-Based Screening Program |
title | The Application of Liver Stiffness Measurement in Residents Without Overt Liver Diseases Through a Community-Based Screening Program |
title_full | The Application of Liver Stiffness Measurement in Residents Without Overt Liver Diseases Through a Community-Based Screening Program |
title_fullStr | The Application of Liver Stiffness Measurement in Residents Without Overt Liver Diseases Through a Community-Based Screening Program |
title_full_unstemmed | The Application of Liver Stiffness Measurement in Residents Without Overt Liver Diseases Through a Community-Based Screening Program |
title_short | The Application of Liver Stiffness Measurement in Residents Without Overt Liver Diseases Through a Community-Based Screening Program |
title_sort | application of liver stiffness measurement in residents without overt liver diseases through a community-based screening program |
topic | 4500 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998410/ https://www.ncbi.nlm.nih.gov/pubmed/27015215 http://dx.doi.org/10.1097/MD.0000000000003193 |
work_keys_str_mv | AT chengpinnan theapplicationofliverstiffnessmeasurementinresidentswithoutovertliverdiseasesthroughacommunitybasedscreeningprogram AT chiuyencheng theapplicationofliverstiffnessmeasurementinresidentswithoutovertliverdiseasesthroughacommunitybasedscreeningprogram AT chiuhungchih theapplicationofliverstiffnessmeasurementinresidentswithoutovertliverdiseasesthroughacommunitybasedscreeningprogram AT chienshihchieh theapplicationofliverstiffnessmeasurementinresidentswithoutovertliverdiseasesthroughacommunitybasedscreeningprogram AT chengpinnan applicationofliverstiffnessmeasurementinresidentswithoutovertliverdiseasesthroughacommunitybasedscreeningprogram AT chiuyencheng applicationofliverstiffnessmeasurementinresidentswithoutovertliverdiseasesthroughacommunitybasedscreeningprogram AT chiuhungchih applicationofliverstiffnessmeasurementinresidentswithoutovertliverdiseasesthroughacommunitybasedscreeningprogram AT chienshihchieh applicationofliverstiffnessmeasurementinresidentswithoutovertliverdiseasesthroughacommunitybasedscreeningprogram |